Signal2026-07-16
ClinicalTrials.gov

[] Preadmission GLP-1 Receptor Agonist Plus SGLT2 Inhibitor Use and Early Outcomes After Pneumonia Hospitalization in Adults With Type 2 Diabetes

Part of

Dynamic Medicine And Treatment Timing

Open primary sourceSee the whole picture